Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain diseases based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Jake Junkil Been, CEO, and Donghyeon Kim, CTO, who developed the next-generation neuro-navigation system.
Major products include brain MRI imaging analysis and interpretation software "Neurophet AQUA", brain PET scan analysis (PET tracer deposition) software "Neurophet SCALE PET", brain electric and magnetic stimulation simulation software "Neurophet tES/TMS Lab", and a brain region of interest analysis research tool "Neurophet SegPlus".
Neurophet has set its top priority to helping patients suffering from brain diseases. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 124, Teheran-Ro, Gangnam-Gu, 12f,samwon Tower,korea, Republic Of
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- https://www.neurophet.com/
- Keywords
- ai, neuroimaging, healthcare, Radiology, Brain, MRI, PET, neuroscience, medicalimaging, Braindisorders, neuroradiologist.
- HQ
- Seoul
Neurophet Questions
Neurophet's website is https://www.neurophet.com/
Neurophet's LinkedIn profile is https://kr.linkedin.com/company/neurophet-en
Neurophet has
4 employees.
View email and phone details for 4
employees at Neurophet.
Neurophet's industry is
Software Development
Neurophet's top competitors are
Inmed.ai,
Neurosync,
Coreline Soft,
Deep Bio Inc.,
Airs Medical,
Ainex Corporation,
Lvis Korea,
뉴로핏 (Neurophet),
Lvis,
Vuno Inc..
Neurophet's categories are Software Development
Neurophet's founding year is 2016
